Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda crawled date : 2020 - 12 - 01 save search
Myovant Sciences Submits New Drug Application (NDA) to the FDA for Once-Daily Relugolix Combination Tablet for the Treatment of Women with Uterine Fibroids
Published: 2020-06-01 (Crawled : 22:15) - globenewswire.com
MYOV | $26.98 -0.04% 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
fda drug new drug treatment application
Myovant Sciences Announces Priority Review and FDA Acceptance of New Drug Application for Once-Daily, Oral Relugolix for Advanced Prostate Cancer
Published: 2020-06-22 (Crawled : 22:15) - globenewswire.com
MYOV | $26.98 -0.04% 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
cancer fda drug prostate cancer fda acceptance new drug
Myovant Sciences Announces FDA Acceptance of New Drug Application for Once-Daily Relugolix Combination Tablet for Uterine Fibroids
Published: 2020-08-17 (Crawled : 22:15) - globenewswire.com
MYOV | $26.98 -0.04% 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
fda drug fda acceptance new drug application
Novan Receives Verbal Guidance from FDA for SB206 and Announces Sato Program Advancement
Published: 2020-04-03 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 6.82%
H: 1.06%
C: -17.64%
fda program
Novan Announces Receipt of Written Minutes from Type C Meeting with FDA Regarding Development of SB206
Published: 2020-04-30 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -2.96%
H: 1.39%
C: -0.69%
fda
VBI Vaccines Announces Submission of Biologics License Application to FDA for 3-Antigen Prophylactic Hepatitis B Vaccine
Published: 2020-12-01 (Crawled : 22:02) - biospace.com/
VBIV | $0.591 -1.99% -2.03% 110K
|
Health Technology
|
| O: 3.94%
H: 1.12%
C: -10.96%
license fda vaccine submission hepatitis application
Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI™ Detection
Published: 2020-12-01 (Crawled : 22:02) - biospace.com/
HOLX | $77.19 1.27% 1.26% 1.6M
|
Health Technology
|
| O: 0.33%
H: 1.18%
C: 0.39%
breast cancer cancer test fda clearance fda clearance
BridgeBio Pharma and Affiliate QED Therapeutics Announce FDA Acceptance of New Drug Application for Infigratinib for the Treatment of Cholangiocarcinoma
Published: 2020-12-01 (Crawled : 22:02) - biospace.com/
BBIO | $25.43 1.44% 1.42% 1.1M
|
Health Technology
|
| O: 1.49%
H: 2.78%
C: 0.27%
fda drug fda acceptance treatment new drug application pharma
Minerva Neurosciences Announces Outcome of Type C Meeting with FDA and Next Steps in the Development of Roluperidone
Published: 2020-12-01 (Crawled : 22:01) - biospace.com/
NERV | $2.55 0.0% 4.6K
|
Health Technology
|
| O: -21.08%
H: 5.86%
C: -5.86%
fda roluperidone
Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations for WP1066
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
MBRX | $4.45 3.49% 3.37% 7.4K
|
Health Technology
|
| O: 41.03%
H: 10.91%
C: -10.0%
disease fda wp1066 approval fda approval designation rare
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.